His team sees this pattern often: someone on metformin for insulin resistance, PCOS, or type 2 diabetes, who assumed the exhaustion was just part of trying to lose weight
Fasting plasma glucose values obtained at routine clinic visits less than 54 mg/dL, irrespective of hypoglycemic symptoms, occurred in 2 (0.1%) SAXENDA-treated patients and 1 (0.1%) placebo-treated patients
Tirzepatide, the first approved dual GIP/GLP-1 receptor agonist, is a 39-amino acid peptide with an approximately 120-hour half-life supporting once-weekly dosing
When you think about other chronic diseases, high blood pressure, high cholesterol, what we found is that the earlier you treat people, the easier it is to treat
But the effect is not confined to any particular GLP-1 medication and can also arise from other interventions that can result in significant weight loss